Safety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)

NCT02425579 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Acute Respiratory Distress Syndrome (ARDS)

Interventions

DRUG: Inhaled Carbon Monoxide at 100ppm (4 participants)
DRUG: Placebo for Inhaled Carbon Monoxide at 100ppm (2 participants)
DRUG: Inhaled Carbon Monoxide at 200ppm (4 participants)
DRUG: Placebo for Inhaled Carbon Monoxide at 200ppm (2 participants)

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]
[object Object]
[object Object]